STAT3 and neoplasm: It has been proposed that the JAK/STAT signaling pathway is involved in the development of UCEC, and targeted inhibition of the IL‐6 receptor and its downstream effectors JAK1 and STAT3 significantly reduces UCEC tumor cell growth.23